Cargando…
Clethra fimbriata hexanic extract triggers alteration in the energy metabolism in epimastigotes of Trypanosoma cruzi
Chagas disease (ChD), caused by Trypanosoma cruzi, is endemic in American countries and an estimated 8 million people worldwide are chronically infected. Currently, only two drugs are available for therapeutic use against T. cruzi and their use is controversial due to several disadvantages associate...
Autores principales: | Pardo-Rodriguez, Daniel, Lasso, Paola, Santamaría-Torres, Mary, Cala, Mónica P., Puerta, Concepción J., Méndez Arteaga, Jonh Jairo, Robles, Jorge, Cuervo, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561390/ https://www.ncbi.nlm.nih.gov/pubmed/37818099 http://dx.doi.org/10.3389/fmolb.2023.1206074 |
Ejemplares similares
-
A terpenoid-rich extract from Clethra fimbriata exhibits anti-Trypanosoma cruzi activity and induces T cell cytokine production()
por: Pardo-Rodriguez, Daniel, et al.
Publicado: (2022) -
Flagellar Motility of Trypanosoma cruzi Epimastigotes
por: Ballesteros-Rodea, G., et al.
Publicado: (2012) -
Proteomic analysis of glycosomes from Trypanosoma cruzi epimastigotes
por: Acosta, Héctor, et al.
Publicado: (2019) -
Erratum to “Flagellar Motility of Trypanosoma cruzi Epimastigotes”
por: Ballesteros-Rodea, G., et al.
Publicado: (2012) -
Consumption of Galactose by Trypanosoma cruzi Epimastigotes Generates Resistance against Oxidative Stress
por: Lobo-Rojas, Ángel, et al.
Publicado: (2022)